Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.
10.3346/jkms.1999.14.1.102
- Author:
Yun Ju CHO
1
;
Dong Soo HAN
;
Think You KIM
;
Se Jin JANG
;
Yong Chul JEON
;
Joo Hyun SOHN
;
In Hong LEE
;
Kyung Nam PARK
Author Information
1. Department of Internal Medicine, Hanyang University, College of Medicine, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Cholangitis, autoimmune;
Antibodies, antimitochondrial;
Liver cirrhosis, biliary;
Antibodies, anticentromere
- MeSH:
Autoantibodies/immunology*;
Case Report;
Cholangitis/pathology;
Cholangitis/immunology*;
Female;
Human;
Liver Cirrhosis, Biliary/pathology;
Liver Cirrhosis, Biliary/immunology*;
Middle Age;
Mitochondria/immunology*
- From:Journal of Korean Medical Science
1999;14(1):102-106
- CountryRepublic of Korea
- Language:English
-
Abstract:
Autoimmune cholangitis is a clinical constellation of chronic cholestasis, histological changes of chronic nonsuppurative cholangitis and the presence of autoantibodies other than antimitochondrial antibody (AMA). It is uncertain whether this entity is definitely different from AMA positive primary biliary cirrhosis (PBC), though it shows some differences. We report a case of autoimmune cholangitis in a 59-year-old woman, who had been previously diagnosed as AMA-positive PBC associated with rheumatoid arthritis, has been converted to an AMA-negative and anticentromere antibody-positive PBC during follow-up. The response to ursodeoxycholic acid treatment is poor except within the first few months, but prednisolone was dropping the biochemical laboratory data.
